Lv3
330 积分 2023-05-23 加入
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
17天前
已完结
Discovery of novel dihydropteridone derivatives as orally bioavailable PLK1 inhibitors with reduced hERG inhibitory activity for acute myeloid leukemia treatment
20天前
已完结
Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site
24天前
已完结
Bone marrow necrosis after treatment with blinatumomab for acute lymphoblastic leukemia: A case report
26天前
已关闭
Diagnosis and treatment of therapy-related acute myeloid leukemia
1个月前
已完结
Cardiac toxicity of brentuximab vedotin: a real-word disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database
1个月前
已完结
Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities—AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM
1个月前
已关闭
A randomised evaluation of low‐dose cytosine arabinoside plus lenalidomide versus single‐agent low‐dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI‐1 trial
1个月前
已完结
Daratumumab with ifosfamide, carboplatin and etoposide for the treatment of relapsed plasmablastic lymphoma
1个月前
已完结
Availability of FLT3 inhibitors: how do we use them?
1个月前
已关闭
皖公网安备34019202002308
